CrossBridgeBio Breaks Through 30 Years of ADC Challenges with Dual Payload Technology

CrossBridgeBio Breaks Through 30 Years of ADC Challenges with Dual Payload Technology

Friends, please click on the above「Medical Intelligence Hardcore Talk」/ Click on the above「 . . .」/ Select「Set as Star」 By 2025, the global ADC (Antibody-Drug Conjugate) market size will exceed $30 billion, yet the confusion among oncologists remains—half of the patients develop resistance during treatment, 15% experience severe side effects due to off-target effects, not … Read more